| 10001 | Physical activity (Total log acceleration 2am-4am) | GCST90061410 | 0.03 |
| 10002 | Cervical cancer | GCST90018597 | 0.03 |
| 10003 | CACYBP levels | GCST90468524 | 0.03 |
| 10004 | Medication use (vasodilators used in cardiac diseases) | GCST90018763 | 0.03 |
| 10005 | Main speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000419 | 0.03 |
| 10006 | Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers) | FING00000877 | 0.03 |
| 10007 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T216 | ECGU000216 | 0.03 |
| 10008 | VASP levels | GCST90471028 | 0.03 |
| 10009 | Nerve, nerve root and plexus disorders | FING00000862 | 0.03 |
| 10010 | Chronic Kidney Disease, Stage IV (PheCode 585.34) | GCST90476130 | 0.03 |
| 10011 | BACH1/SNX9 ratio | GCST90313447 | 0.03 |
| 10012 | Ganglion cell inner plexiform layer (GCIPL) thickness | GCST90014267 | 0.03 |
| 10013 | Alcohol usually taken with meals (UKB data field 1618) | GCST90133004 | 0.03 |
| 10014 | MARS1 levels | GCST90469862 | 0.03 |
| 10015 | DTI autoptx MD atr r tract | GCST90385223 | 0.03 |
| 10016 | Left-hemisphere salience/ventral attention network to right-hemisphere control network white-matter structural connectivity | GCST90302717 | 0.03 |
| 10017 | CCBL2 levels | GCST90241722 | 0.03 |
| 10018 | Heart attack | GCST90475211 | 0.03 |
| 10019 | IDP dMRI TBSS MD Middle cerebellar peduncle | GCST90004027 | 0.03 |
| 10020 | Ankylosing spondylitis, strict definition | FING00000090 | 0.03 |
| 10021 | Abdominal hernia | digestive | UKBB00000002 | 0.03 |
| 10022 | AGXT/GRPEL1 ratio | GCST90313205 | 0.03 |
| 10023 | LY6D/NECTIN4 ratio | GCST90315344 | 0.03 |
| 10024 | INSL4 levels | GCST90469621 | 0.03 |
| 10025 | CABP2 levels | GCST90468519 | 0.03 |
| 10026 | Mean sphered cell volume | Blood count | UKBB00000452 | 0.03 |
| 10027 | Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivity | GCST90302760 | 0.03 |
| 10028 | Ankle spacing width (right) | Bone-densitometry of heel | UKBB00000034 | 0.03 |
| 10029 | aparc-a2009s lh area Pole-temporal | GCST90003339 | 0.03 |
| 10030 | aparc-Desikan lh volume precentral | GCST90002791 | 0.03 |
| 10031 | BA-exvivo rh thickness BA1 | GCST90003527 | 0.03 |
| 10032 | Financial situation satisfaction | Mental health | UKBB00000249 | 0.03 |
| 10033 | aparc-DKTatlas rh thickness lingual | GCST90003582 | 0.03 |
| 10034 | Smoking dependency | FING00001315 | 0.03 |
| 10035 | Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000429 | 0.03 |
| 10036 | Deep bite | FING00000380 | 0.03 |
| 10037 | Systolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000806 | 0.03 |
| 10038 | Left ventricular end systole anterospetal wall thickness | GCST90278513 | 0.03 |
| 10039 | HippSubfield rh volume CA3-head | GCST90002707 | 0.03 |
| 10040 | Malignant neoplasm of female breast | neoplasms | UKBB00000426 | 0.03 |
| 10041 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T113 | ECGA000113 | 0.03 |
| 10042 | Diaphragmatic hernia | FING00000419 | 0.03 |
| 10043 | SNAP29/SNX9 ratio | GCST90315859 | 0.03 |
| 10044 | XPNPEP2 levels | GCST90471084 | 0.03 |
| 10045 | GAPDH levels | GCST90469302 | 0.03 |
| 10046 | Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31) | GCST90476116 | 0.03 |
| 10047 | rfMRI connectivity (ICA100 edge 995) | GCST90005848 | 0.03 |
| 10048 | Dorsopathies | FING00000473 | 0.03 |
| 10049 | Personal history of certain other diseases | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000642 | 0.03 |
| 10050 | CD93/CLEC14A ratio | GCST90313921 | 0.03 |
| 10051 | KLF4 levels | GCST90469694 | 0.03 |
| 10052 | Hypoplasia of dental enamel, including avohilmo | FING00000652 | 0.03 |
| 10053 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000436 | 0.03 |
| 10054 | Ceramide (d17:1/22:0) levels | GCST90024032 | 0.03 |
| 10055 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320649 | 0.03 |
| 10056 | NEXN levels | GCST90470030 | 0.03 |
| 10057 | Sensorineural hearing loss | FING00001291 | 0.03 |
| 10058 | FADD/LACTB2 ratio | GCST90314767 | 0.03 |
| 10059 | ITGB1/SELP ratio | GCST90315230 | 0.03 |
| 10060 | CETN3 levels | GCST90468722 | 0.03 |
| 10061 | aparc-a2009s lh area G-precuneus | GCST90003326 | 0.03 |
| 10062 | CDH5/NOTCH1 ratio | GCST90313957 | 0.03 |
| 10063 | DTI TBSS L3 Posterior limb of internal capsule R | GCST90384542 | 0.03 |
| 10064 | CR2/TNFRSF13B ratio | GCST90314225 | 0.03 |
| 10065 | Lung function (FEV1/FVC) | GCST90025978 | 0.03 |
| 10066 | CCDC50 levels | GCST90468561 | 0.03 |
| 10067 | Serum 25-Hydroxyvitamin D levels | GCST90000614 | 0.03 |
| 10068 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T44 | ECGA000044 | 0.03 |
| 10069 | Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary Operations | UKBB00000587 | 0.03 |
| 10070 | Diastolic blood pressure | GCST90301698 | 0.03 |
| 10071 | HS1BP3 levels | GCST90469477 | 0.03 |
| 10072 | IDP dMRI ProbtrackX MO str r | GCST90004024 | 0.03 |
| 10073 | Other hammer toe(s) (acquired) | FING00001054 | 0.03 |
| 10074 | Coronary artery calcification | GCST90503074 | 0.03 |
| 10075 | Diaphragmatic hernia | digestive | UKBB00000171 | 0.03 |
| 10076 | AHSP levels | GCST90468264 | 0.03 |
| 10077 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T499 | ECGA000499 | 0.03 |
| 10078 | Diseases of arteries, arterioles and capillaries (FINNGEN) | FING00000423 | 0.03 |
| 10079 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476 | ECGU000476 | 0.03 |
| 10080 | Operative procedures - Primary total prosthetic replacement of knee joint using cement | Summary Operations | UKBB00000588 | 0.03 |
| 10081 | aseg lh intensity Inf-Lat-Vent | GCST90003765 | 0.03 |
| 10082 | Peripheral vascular disease, unspecified (PheCode 443.9) | GCST90475998 | 0.03 |
| 10083 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 0.03 |
| 10084 | Benign neoplasm: Sigmoid colon | FING00000203 | 0.03 |
| 10085 | FOXO3/MAP3K5 ratio | GCST90314880 | 0.03 |
| 10086 | RAP1A levels | GCST90470425 | 0.03 |
| 10087 | Wheeze or whistling in the chest in last year | Breathing | UKBB00000912 | 0.03 |
| 10088 | rfMRI amplitudes (ICA100 node 40) | GCST90004628 | 0.03 |
| 10089 | Acute myocardial infarction | Ischaemic heart diseases | UKBB00000011 | 0.03 |
| 10090 | Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditions | UKBB00000519 | 0.03 |
| 10091 | Plasma iron levels | GCST90100546 | 0.03 |
| 10092 | PLXDC1 levels | GCST90470263 | 0.03 |
| 10093 | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels | GCST90200070 | 0.03 |
| 10094 | HippSubfield rh volume CA1-body | GCST90002692 | 0.03 |
| 10095 | Descending aorta distensibility | GCST90267386 | 0.03 |
| 10096 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5 | ECGU000005 | 0.03 |
| 10097 | ELOA/POLR2F ratio | GCST90314643 | 0.03 |
| 10098 | IDP dMRI TBSS MO Cerebral peduncle L | GCST90003967 | 0.03 |
| 10099 | BCR/FOXO1 ratio | GCST90313490 | 0.03 |
| 10100 | Hypertension | GCST90468135 | 0.03 |
| 10101 | Solitary pulmonary nodule (PheCode 514.2) | GCST90476044 | 0.03 |
| 10102 | Inguinal hernia, bilateral | FING00000682 | 0.03 |
| 10103 | TNC/VCAM1 ratio | GCST90315927 | 0.03 |
| 10104 | rfMRI amplitudes (ICA100 node 38) | GCST90004626 | 0.03 |
| 10105 | Left-hemisphere visual network to left-hemisphere limbic network white-matter structural connectivity | GCST90302652 | 0.03 |
| 10106 | Dorsalgia | FING00000472 | 0.03 |
| 10107 | Hernia abdominopelvic cavity | GCST90086087 | 0.03 |
| 10108 | MTSS1 levels | GCST90469960 | 0.03 |
| 10109 | Congenital malformations of ovaries, fallopian tubes and broad ligaments | FING00000337 | 0.03 |
| 10110 | Cervicobrachial syndrome | FING00000266 | 0.03 |
| 10111 | Liver fat | GCST90029073 | 0.03 |
| 10112 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499831 | 0.03 |
| 10113 | Tryptophan levels | GCST90243403 | 0.03 |
| 10114 | aparc-Desikan rh thickness lingual | GCST90003491 | 0.03 |
| 10115 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320567 | 0.03 |
| 10116 | Glucosamine medication | FING00000584 | 0.03 |
| 10117 | T1 FreeSurfer aseg Right-Lateral-Ventricle | GCST90384157 | 0.03 |
| 10118 | KIFBP/TACC3 ratio | GCST90315249 | 0.03 |
| 10119 | NPDC1 levels | GCST90470069 | 0.03 |
| 10120 | aparc-a2009s lh area S-calcarine | GCST90003340 | 0.03 |
| 10121 | Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618) | GCST90132926 | 0.03 |
| 10122 | IGFBP2 levels | GCST90469528 | 0.03 |
| 10123 | Right-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302787 | 0.03 |
| 10124 | NBL1 levels | GCST90470001 | 0.03 |
| 10125 | Hair/balding pattern: Pattern 1 (UKB data field 2395_1) | GCST90043616 | 0.03 |
| 10126 | T1 CAT volume L TemporalOccipitalFusiformCortex | GCST90384076 | 0.03 |
| 10127 | Asthma | Chronic lower respiratory diseases | UKBB00000053 | 0.03 |
| 10128 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 0.03 |
| 10129 | aparc-a2009s lh area S-postcentral | GCST90003363 | 0.03 |
| 10130 | GNPDA2 levels | GCST90469374 | 0.03 |
| 10131 | IDP dMRI TBSS MO Anterior corona radiata R | GCST90003974 | 0.03 |
| 10132 | Heart attack | GCST90468132 | 0.03 |
| 10133 | CPB1/PRSS2 ratio | GCST90314211 | 0.03 |
| 10134 | C1QTNF1/COL4A1 ratio | GCST90313552 | 0.03 |
| 10135 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000440 | 0.03 |
| 10136 | Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivity | GCST90302674 | 0.03 |
| 10137 | Chronic lower respiratory diseases | FING00000290 | 0.03 |
| 10138 | Estimated glomerular filtration rate (creatinine) | GCST90103634 | 0.03 |
| 10139 | Triacylglycerol_50:5_[M+NH4]1+ levels | GCST90060463 | 0.03 |
| 10140 | MPO levels | GCST90012031 | 0.03 |
| 10141 | Glaucoma (primary open-angle) | GCST90011768 | 0.03 |
| 10142 | How many years have you or did you smoke cigarettes? (inv-normal transformed) | GCST90476390 | 0.03 |
| 10143 | Left-hemisphere dorsal attention network to right-hemisphere limbic network white-matter structural connectivity | GCST90302698 | 0.03 |
| 10144 | GPKOW/PXN ratio | GCST90314978 | 0.03 |
| 10145 | CDH5/PCDH17 ratio | GCST90313958 | 0.03 |
| 10146 | T1 FreeSurfer DK rh lateraloccipital area | GCST90385699 | 0.03 |
| 10147 | PCDH12 levels | GCST90470168 | 0.03 |
| 10148 | Seborrheic dermatitis (PheCode 690.1) | GCST90476171 | 0.03 |
| 10149 | Social and economic stability (confirmatory factor analysis Factor 15) | GCST90309349 | 0.03 |
| 10150 | CD99 levels | GCST90468658 | 0.02 |
| 10151 | Frailty (General Factor) | GCST90624046 | 0.02 |
| 10152 | Hypertension, essential | FING00000638 | 0.02 |
| 10153 | TCTN3 levels | GCST90470823 | 0.02 |
| 10154 | Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivity | GCST90302673 | 0.02 |
| 10155 | Migraine with aura and triptan purchases | FING00000820 | 0.02 |
| 10156 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000435 | 0.02 |
| 10157 | mean corpuscular volume (MCV, minimum, inv-norm transformed) | GCST90475474 | 0.02 |
| 10158 | LACRT levels | GCST90469725 | 0.02 |
| 10159 | creatinine (mean, inv-norm transformed) | GCST90475229 | 0.02 |
| 10160 | Cholesteryl esters in medium VLDL (UKB data field 23506) | GCST90269603 | 0.02 |
| 10161 | Acceptance of an invitation to participate in a mental health questionnaire | GCST90012792 | 0.02 |
| 10162 | FSTL3/SPON2 ratio | GCST90314884 | 0.02 |
| 10163 | MST1 levels | GCST90469952 | 0.02 |
| 10164 | Asthma (only as main-diagnosis) (more control exclusions) | FING00000114 | 0.02 |
| 10165 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000805 | 0.02 |
| 10166 | CLEC14A levels | GCST90468766 | 0.02 |
| 10167 | Cognitive processing accuracy | GCST90446169 | 0.02 |
| 10168 | TFF3 levels | GCST90470837 | 0.02 |
| 10169 | BA-exvivo rh area perirhinal | GCST90003233 | 0.02 |
| 10170 | aparc-pial lh area superiorparietal | GCST90003169 | 0.02 |
| 10171 | CCL11 levels | GCST90274764 | 0.02 |
| 10172 | Excessive vomiting in pregnancy | FING00000523 | 0.02 |
| 10173 | LRP11 levels | GCST90469796 | 0.02 |
| 10174 | ULBP2 levels | GCST90471008 | 0.02 |
| 10175 | estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | GCST90475282 | 0.02 |
| 10176 | aparc-a2009s lh volume G+S-subcentral | GCST90002928 | 0.02 |
| 10177 | Atopic dermatitis | GCST90018564 | 0.02 |
| 10178 | Carnitine levels | GCST90199621 | 0.02 |
| 10179 | CAG-177 sp003514385 abundance in stool | GCST90032259 | 0.02 |
| 10180 | IDP dMRI TBSS MD Inferior cerebellar peduncle L | GCST90004038 | 0.02 |
| 10181 | Smoking status, ever vs never | Other measurement | UKBB00000782 | 0.02 |
| 10182 | Waist circumference | Body size measures | UKBB00000904 | 0.02 |
| 10183 | Added salt consumption | GCST90133001 | 0.02 |
| 10184 | Treatment/medication code - seretide 50 evohaler | Medications | UKBB00000858 | 0.02 |
| 10185 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50 | ECGA000050 | 0.02 |
| 10186 | Non-oily fish intake | Diet | UKBB00000525 | 0.02 |
| 10187 | X-21471 levels | GCST90200586 | 0.02 |
| 10188 | IDP dMRI ProbtrackX L3 slf l | GCST90004321 | 0.02 |
| 10189 | Sphingomyelin_42:3_[M+H]1+ levels | GCST90060399 | 0.02 |
| 10190 | COL18A1 levels | GCST90468812 | 0.02 |
| 10191 | ANKMY2 levels | GCST90468309 | 0.02 |
| 10192 | NAGPA levels | GCST90242004 | 0.02 |
| 10193 | Arthropathies | FING00000107 | 0.02 |
| 10194 | CELSR2 levels | GCST90468703 | 0.02 |
| 10195 | IDP T1 FAST ROIs L planum temporale | GCST90002541 | 0.02 |
| 10196 | Asthma | respiratory | UKBB00000054 | 0.02 |
| 10197 | Snoring | GCST009761 | 0.02 |
| 10198 | DTI autoptx MD ilf r tract | GCST90385235 | 0.02 |
| 10199 | Benign neoplasm: Rectum, anus and anal canal | FING00000197 | 0.02 |
| 10200 | aparc-DKTatlas rh area lateraloccipital | GCST90003274 | 0.02 |
| 10201 | T1 FreeSurfer a2009s lh G front sup thickness | GCST90384757 | 0.02 |
| 10202 | Concentration of small LDL particles | GCST90499669 | 0.02 |
| 10203 | Never eat eggs, dairy, wheat, sugar - I eat all of the above | Diet | UKBB00000500 | 0.02 |
| 10204 | SLC27A4 levels | GCST90470657 | 0.02 |
| 10205 | FKBPL levels | GCST90469246 | 0.02 |
| 10206 | EFEMP1/TGFBR3 ratio | GCST90314597 | 0.02 |
| 10207 | SOD1 levels | GCST90470704 | 0.02 |
| 10208 | FOXJ3 levels | GCST90469264 | 0.02 |
| 10209 | CD276 levels | GCST90468614 | 0.02 |
| 10210 | Tyrosine levels (UKB data field 23469) | GCST90269566 | 0.02 |
| 10211 | Other diseases of intestines | FING00001001 | 0.02 |
| 10212 | wg lh intensity-contrast bankssts | GCST90003793 | 0.02 |
| 10213 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114) | GCST90320677 | 0.02 |
| 10214 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 28) | GCST90320847 | 0.02 |
| 10215 | Oral glucose tolerance test-2h | GCST90297790 | 0.02 |
| 10216 | Atrophic disorders of skin | FING00000129 | 0.02 |
| 10217 | CDKN2D/TACC3 ratio | GCST90313992 | 0.02 |
| 10218 | IL15/IL18BP ratio | GCST90315148 | 0.02 |
| 10219 | CKMT1A or CKMT1B levels | GCST90468760 | 0.02 |
| 10220 | Triacylglycerol_45:4_[M+NH4]1+ levels | GCST90060333 | 0.02 |
| 10221 | OGN levels | GCST90470119 | 0.02 |
| 10222 | TP53I3 levels | GCST90470937 | 0.02 |
| 10223 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000804 | 0.02 |
| 10224 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T92 | ECGU000092 | 0.02 |
| 10225 | Mean corpuscular haemoglobin | Blood count | UKBB00000447 | 0.02 |
| 10226 | DTI TBSS FA Sagittal stratum L | GCST90384411 | 0.02 |
| 10227 | aparc-a2009s rh volume S-orbital-H-Shaped | GCST90003062 | 0.02 |
| 10228 | EPHA4 levels | GCST90469131 | 0.02 |
| 10229 | Triacylglycerol_53:5_[M+NH4]1+ levels | GCST90060520 | 0.02 |
| 10230 | aparc-Desikan rh area lateraloccipital | GCST90003117 | 0.02 |
| 10231 | Body mass index | GCST90018727 | 0.02 |
| 10232 | CPA1/PLA2G1B ratio | GCST90314205 | 0.02 |
| 10233 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T210 | ECGU000210 | 0.02 |
| 10234 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28 | ECGA000028 | 0.02 |
| 10235 | Androstenediol (3beta,17beta) monosulfate (1) levels | GCST90199872 | 0.02 |
| 10236 | DTI autoptx L1 ptr r tract | GCST90385159 | 0.02 |
| 10237 | T1 FreeSurfer DK rh fusiform volume | GCST90385763 | 0.02 |
| 10238 | Asthma | GCST90014325 | 0.02 |
| 10239 | Tryptophan betaine levels | GCST90199819 | 0.02 |
| 10240 | Breast cancer (PheCode 174) | GCST90435600 | 0.02 |
| 10241 | DTI TBSS FA Uncinate fasciculus L | GCST90384425 | 0.02 |
| 10242 | aparc-pial rh area postcentral | GCST90003195 | 0.02 |
| 10243 | AMBP levels | GCST90468288 | 0.02 |
| 10244 | Vascular/heart problems diagnosed by doctor - None of the above | Medical conditions | UKBB00000899 | 0.02 |
| 10245 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000439 | 0.02 |
| 10246 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75 | ECGA000075 | 0.02 |
| 10247 | KLK4 levels | GCST90469704 | 0.02 |
| 10248 | ATXN2L levels | GCST90468402 | 0.02 |
| 10249 | Haemoglobin concentration (UKB data field 30020) | GCST90468074 | 0.02 |
| 10250 | DTI TBSS L2 Anterior limb of internal capsule L | GCST90384493 | 0.02 |
| 10251 | 1,2-dipalmitoyl-GPC (16:0/16:0) metabolite level | GCST90615438 | 0.02 |
| 10252 | aparc-DKTatlas lh volume lingual | GCST90002873 | 0.02 |
| 10253 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119) | GCST90320938 | 0.02 |
| 10254 | Spirits liking | GCST90094848 | 0.02 |
| 10255 | DTI TBSS MD Retrolenticular part of internal capsule L | GCST90384593 | 0.02 |
| 10256 | Mean reticulocyte volume | GCST90025975 | 0.02 |
| 10257 | Gallbladder polyp | GCST90018626 | 0.02 |
| 10258 | rfMRI amplitudes (ICA100 node 30) | GCST90004618 | 0.02 |
| 10259 | Diabetes mellitus (PheCode 250) | GCST90475658 | 0.02 |
| 10260 | IDP dMRI TBSS OD Cerebral peduncle R | GCST90004416 | 0.02 |
| 10261 | MTHFSD levels | GCST90469956 | 0.02 |
| 10262 | CFHR4 levels | GCST90019045 | 0.02 |
| 10263 | Caries in Clefts patients | FING00000256 | 0.02 |
| 10264 | Immature fraction of reticulocytes | GCST90002387 | 0.02 |
| 10265 | Corneal dystrophy (PheCode 364.5) | GCST90475864 | 0.02 |
| 10266 | Other acute lower respiratory infections | FING00000921 | 0.02 |
| 10267 | Principal component-derived dietary pattern 23 | GCST90133028 | 0.02 |
| 10268 | MYDGF levels | GCST90469972 | 0.02 |
| 10269 | T1 FreeSurfer pial rh lateraloccipital area | GCST90385832 | 0.02 |
| 10270 | Uric acid levels | GCST90278646 | 0.02 |
| 10271 | Percentage of invited food questionnaires completed | GCST90012790 | 0.02 |
| 10272 | aparc-a2009s rh area G-oc-temp-lat-fusifor | GCST90003391 | 0.02 |
| 10273 | Allergic asthma (mode) | FING00000066 | 0.02 |
| 10274 | Serum 25-Hydroxyvitamin D levels | GCST90000618 | 0.02 |
| 10275 | ST13 levels | GCST90470751 | 0.02 |
| 10276 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461 | ECGU000461 | 0.02 |
| 10277 | CSNK1G2 levels | GCST90240608 | 0.02 |
| 10278 | BA-exvivo rh volume BA6 | GCST90002855 | 0.02 |
| 10279 | Treatment or medication use - insulin product (UKB data field 20003_1140883066) | GCST90042226 | 0.02 |
| 10280 | Treatment/medication code - lisinopril | Medications | UKBB00000850 | 0.02 |
| 10281 | Corneal resistance factor | GCST90100568 | 0.02 |
| 10282 | Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000641 | 0.02 |
| 10283 | Thyroid stimulating hormone levels | GCST90296333 | 0.02 |
| 10284 | SPINT2/TNFSF13 ratio | GCST90315879 | 0.02 |
| 10285 | aparc-a2009s lh area S-orbital-med-olfact | GCST90003359 | 0.02 |
| 10286 | IL2RB levels | GCST90469586 | 0.02 |
| 10287 | 2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels | GCST90200233 | 0.02 |
| 10288 | Physical activity (Total log acceleration 6am-8am) | GCST90061412 | 0.02 |
| 10289 | 10-undecenoate (11:1n1) levels | GCST90243596 | 0.02 |
| 10290 | Duration to first press of snap-button in each round | Reaction time | UKBB00000202 | 0.02 |
| 10291 | CRYBB2 levels | GCST90468875 | 0.02 |
| 10292 | DTI TBSS MD Fornix cres+Stria terminalis L | GCST90384611 | 0.02 |
| 10293 | Waist circumference (UKB data field 48) | GCST90468182 | 0.02 |
| 10294 | ThalamNuclei lh volume VLp | GCST90002734 | 0.02 |
| 10295 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497929 | 0.02 |
| 10296 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 0.02 |
| 10297 | Serum 25-Hydroxyvitamin D levels (conditioned on BMI) | GCST90000616 | 0.02 |
| 10298 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80 | ECGA000080 | 0.02 |
| 10299 | DTI TBSS MD Anterior limb of internal capsule R | GCST90384588 | 0.02 |
| 10300 | DTI TBSS L1 Fornix | GCST90384433 | 0.02 |
| 10301 | Kiwi liking | GCST90094788 | 0.02 |
| 10302 | Principal component-derived dietary pattern 19 | GCST90133024 | 0.02 |
| 10303 | aparc-a2009s lh volume S-subparietal | GCST90002995 | 0.02 |
| 10304 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482 | ECGA000482 | 0.02 |
| 10305 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320895 | 0.02 |
| 10306 | DCTD levels | GCST90468957 | 0.02 |
| 10307 | wg rh intensity-contrast caudalmiddlefrontal | GCST90003830 | 0.02 |
| 10308 | Waist circumference | GCST90278648 | 0.02 |
| 10309 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000809 | 0.02 |
| 10310 | CA13/TIA1 ratio | GCST90313567 | 0.02 |
| 10311 | Coronary artery / coronary heart disease (including heart attack, angina) | GCST90475198 | 0.02 |
| 10312 | aparc-DKTatlas rh area precuneus | GCST90003288 | 0.02 |
| 10313 | DTI TBSS MD Tapetum L | GCST90384619 | 0.02 |
| 10314 | DTI autoptx L2 atr r tract | GCST90385169 | 0.02 |
| 10315 | VWC2L levels | GCST90471063 | 0.02 |
| 10316 | Breast cancer | neoplasms | UKBB00000109 | 0.02 |
| 10317 | Other intervertebral disk disorders | Other dorsopathies | UKBB00000612 | 0.02 |
| 10318 | Hematocrit | GCST90002304 | 0.02 |
| 10319 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T29 | ECGA000029 | 0.02 |
| 10320 | TNFRSF4 levels | GCST90470913 | 0.02 |
| 10321 | IDP dMRI TBSS L3 Inferior cerebellar peduncle L | GCST90004182 | 0.02 |
| 10322 | Diaphragmatic hernia (PheCode 550.2) | GCST90476061 | 0.02 |
| 10323 | Viral haemorrhagic fevers, not elsewhere classified/unspecified | FING00001433 | 0.02 |
| 10324 | Baked/steamed fish liking | GCST90094696 | 0.02 |
| 10325 | Mosaic chromosomal alteration of the X chromosome | GCST90165287 | 0.02 |
| 10326 | SLC51B levels | GCST90470664 | 0.02 |
| 10327 | Pulse pressure | GCST90472784 | 0.02 |
| 10328 | Daytime nap | GCST011494 | 0.02 |
| 10329 | DTX3 levels | GCST90469048 | 0.02 |
| 10330 | IDP dMRI TBSS L2 Superior cerebellar peduncle R | GCST90004135 | 0.02 |
| 10331 | T1 FreeSurfer DK rh cuneus volume | GCST90385761 | 0.02 |
| 10332 | DTI TBSS L2 Posterior thalamic radiation R | GCST90384504 | 0.02 |
| 10333 | NID1/NID2 ratio | GCST90315541 | 0.02 |
| 10334 | EPHA2 levels | GCST90469130 | 0.02 |
| 10335 | Primary coxarthrosis, bilateral | FING00001212 | 0.02 |
| 10336 | Congenital malformations of genital organs | FING00000333 | 0.02 |
| 10337 | 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels | GCST90200065 | 0.02 |
| 10338 | CD46/SELP ratio | GCST90313834 | 0.02 |
| 10339 | aparc-a2009s rh volume S-intrapariet+P-trans | GCST90003054 | 0.02 |
| 10340 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000808 | 0.02 |
| 10341 | Hemoglobin concentration | GCST90002310 | 0.02 |
| 10342 | Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302658 | 0.02 |
| 10343 | Preeclampsia or other maternal hypertension (maternal genotype effect) | GCST90269904 | 0.02 |
| 10344 | COPD/asthma/ILD related infections | FING00000353 | 0.02 |
| 10345 | Mean corpuscular hemoglobin | GCST90002390 | 0.02 |
| 10346 | Concentration of IDL particles (UKB data field 23523) | GCST90269620 | 0.02 |
| 10347 | Arthrosis | FING00000111 | 0.02 |
| 10348 | CDC26 levels | GCST90468663 | 0.02 |
| 10349 | DHX58 levels | GCST90618238 | 0.02 |
| 10350 | DRAXIN levels | GCST90469038 | 0.02 |
| 10351 | ITGB1BP2/STAT5B ratio | GCST90315220 | 0.02 |
| 10352 | Right-hemisphere control network to putamen white-matter structural connectivity | GCST90302838 | 0.02 |
| 10353 | Phosphatidylcholine acyl-alkyl C36:5 levels | GCST90240073 | 0.02 |
| 10354 | Potassium in urine | Urine assays | UKBB00000655 | 0.02 |
| 10355 | BA-exvivo lh area BA2 | GCST90003208 | 0.02 |
| 10356 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T455 | ECGU000455 | 0.02 |
| 10357 | Mononeuropathies of upper limb | Nerve, nerve root and plexus disorders | UKBB00000481 | 0.02 |
| 10358 | BA-exvivo lh area V2 | GCST90003217 | 0.02 |
| 10359 | Vaginitis/vulvovaginitis/vulvitis/abscess of vulva | FING00001412 | 0.02 |
| 10360 | Cerebrospinal fluid sulfate* levels | GCST90318056 | 0.02 |
| 10361 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473 | ECGU000473 | 0.02 |
| 10362 | CNTN3 levels | GCST90468805 | 0.02 |
| 10363 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24 | ECGA000024 | 0.02 |
| 10364 | Spread type: Any oil based spread vs never use spread (UKB data field 1428) | GCST90132949 | 0.02 |
| 10365 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | GCST90320825 | 0.02 |
| 10366 | Deep vein thrombosis [DVT] (PheCode 452.2) | GCST90476010 | 0.02 |
| 10367 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 0.02 |
| 10368 | Breast cancer [female] | neoplasms | UKBB00000108 | 0.02 |
| 10369 | Principal component-derived dietary pattern 31 | GCST90133036 | 0.02 |
| 10370 | ICD10 N84: Polyp of female genital tract | GCST90454216 | 0.02 |
| 10371 | Tobacco use | FING00001365 | 0.02 |
| 10372 | Methods of admission to hospital (recoded) - Elective admission: Planned | Summary Administration | UKBB00000462 | 0.02 |
| 10373 | IDP dMRI TBSS ICVF Uncinate fasciculus R | GCST90004371 | 0.02 |
| 10374 | CELA2A levels | GCST90468701 | 0.02 |
| 10375 | COL9A1 levels | GCST90468822 | 0.02 |
| 10376 | Right-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302834 | 0.02 |
| 10377 | Proline levels | GCST90243457 | 0.02 |
| 10378 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427 | ECGU000427 | 0.02 |
| 10379 | Spinal stenosis | FING00001322 | 0.02 |
| 10380 | Falls in the last year | General health | UKBB00000235 | 0.02 |
| 10381 | IDP dMRI ProbtrackX L2 slf l | GCST90004294 | 0.02 |
| 10382 | TNFRSF13B/TNFSF13B ratio | GCST90315933 | 0.02 |
| 10383 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91 | ECGU000091 | 0.02 |
| 10384 | Leisure/social activities - Sports club or gym | Social support | UKBB00000402 | 0.02 |
| 10385 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T47 | ECGA000047 | 0.02 |
| 10386 | MAP2K6/MGMT ratio | GCST90315373 | 0.02 |
| 10387 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498058 | 0.02 |
| 10388 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46 | ECGA000046 | 0.02 |
| 10389 | aparc-a2009s lh area G-parietal-sup | GCST90003323 | 0.02 |
| 10390 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320644 | 0.02 |
| 10391 | aparc-a2009s lh thickness G-cuneus | GCST90003613 | 0.02 |
| 10392 | aseg global volume CSF | GCST90002603 | 0.02 |
| 10393 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2 | ECGA000002 | 0.02 |
| 10394 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426 | ECGU000426 | 0.02 |
| 10395 | Hard cardiovascular diseases | FING00000602 | 0.02 |
| 10396 | Plasma taurocholenate sulfate* levels in chronic kidney disease | GCST90266040 | 0.02 |
| 10397 | DTI TBSS MD Superior longitudinal fasciculus R | GCST90384612 | 0.02 |
| 10398 | STXBP1 levels | GCST90470777 | 0.02 |
| 10399 | Treatment/medication code - co-codamol | Medications | UKBB00000845 | 0.02 |
| 10400 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 31) | GCST90320850 | 0.02 |
| 10401 | Type 2 diabetes (PheCode 250.2) | GCST90475667 | 0.02 |
| 10402 | Drink temperature | GCST90133002 | 0.02 |
| 10403 | FOXO3/SH2B3 ratio | GCST90314881 | 0.02 |
| 10404 | Femur length to body height ratio | GCST90270256 | 0.02 |
| 10405 | Number of days/week of moderate physical activity 10+ minutes | Physical activity | UKBB00000533 | 0.01 |
| 10406 | Volume of left paralaminar nucleus | GCST90474982 | 0.01 |
| 10407 | IDP dMRI TBSS L1 Cingulum hippocampus L | GCST90004112 | 0.01 |
| 10408 | TWF2 levels | GCST90470987 | 0.01 |
| 10409 | Retinal venular width | GCST90270400 | 0.01 |
| 10410 | Leucine levels (UKB data field 23466) | GCST90269563 | 0.01 |
| 10411 | aparc-Desikan lh area supramarginal | GCST90003103 | 0.01 |
| 10412 | Biological Father: High blood pressure | GCST90475243 | 0.01 |
| 10413 | LYZL2 levels | GCST90469833 | 0.01 |
| 10414 | LDLR levels | GCST90179346 | 0.01 |
| 10415 | CST3 levels | UKBB00000163 | 0.01 |
| 10416 | Total lipid levels in IDL | GCST90132633 | 0.01 |
| 10417 | Waist circumference adjusted for body mass index | GCST90302892 | 0.01 |
| 10418 | Raynaud's syndrome | GCST90448187 | 0.01 |
| 10419 | Carpal tunnel syndrome | FING00000257 | 0.01 |
| 10420 | DNMBP/TBC1D5 ratio | GCST90314519 | 0.01 |
| 10421 | Common executive function | GCST90503115 | 0.01 |
| 10422 | Melanomas of skin (PheCode 172.11) | GCST90475578 | 0.01 |
| 10423 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497969 | 0.01 |
| 10424 | aparc-a2009s lh area S-subparietal | GCST90003367 | 0.01 |
| 10425 | red blood cell count (RBC, maximum, inv-norm transformed) | GCST90476345 | 0.01 |
| 10426 | MANSC1/PODXL2 ratio | GCST90315371 | 0.01 |
| 10427 | DTI autoptx L1 fmi tract | GCST90385150 | 0.01 |
| 10428 | N-formylanthranilic acid levels | GCST90199960 | 0.01 |
| 10429 | Principal component-derived dietary pattern 18 | GCST90133023 | 0.01 |
| 10430 | BA-exvivo rh volume V2 | GCST90002859 | 0.01 |
| 10431 | COX5B/FXN ratio | GCST90314199 | 0.01 |
| 10432 | HippSubfield rh volume Whole-hippocampal-body | GCST90002709 | 0.01 |
| 10433 | Chronic dermatitis due to solar radiation (PheCode 938.2) | GCST90476288 | 0.01 |
| 10434 | Current employment status - Unable to work because of sickness or disability | Employment | UKBB00000160 | 0.01 |
| 10435 | FABP4 levels | GCST90469176 | 0.01 |
| 10436 | Pain type(s) experienced in last month - Knee pain | Pain | UKBB00000629 | 0.01 |
| 10437 | RAPGEF2 levels | GCST90470426 | 0.01 |
| 10438 | Sphingomyelin_40:3_[M+H]1+ levels | GCST90060348 | 0.01 |
| 10439 | Bread type - Wholemeal or wholegrain | Diet | UKBB00000107 | 0.01 |
| 10440 | Total lipids in large LDL | GCST90498021 | 0.01 |
| 10441 | DTI autoptx MD slf r tract | GCST90385242 | 0.01 |
| 10442 | Non-cancer illness code, self-reported - hypertension | Medical conditions | UKBB00000517 | 0.01 |
| 10443 | IDP dMRI TBSS MO Middle cerebellar peduncle | GCST90003952 | 0.01 |
| 10444 | Osteopathies and chondropathies | FING00000913 | 0.01 |
| 10445 | HippSubfield lh volume subiculum-head | GCST90002671 | 0.01 |
| 10446 | Gonarthrosis [arthrosis of knee] | Arthrosis | UKBB00000290 | 0.01 |
| 10447 | ICD10 N92: Excessive, frequent and irregular menstruation | GCST90454221 | 0.01 |
| 10448 | Asparagine levels | GCST90243758 | 0.01 |
| 10449 | Benign paroxysmal vertigo | FING00000210 | 0.01 |
| 10450 | Chalazion | FING00000267 | 0.01 |
| 10451 | DTI TBSS L3 Anterior limb of internal capsule L | GCST90384541 | 0.01 |
| 10452 | LDL cholesterol levels | GCST90498353 | 0.01 |
| 10453 | Volume of left lateral nucleus | GCST90474970 | 0.01 |
| 10454 | Corneal resistance factor | GCST90308682 | 0.01 |
| 10455 | rfMRI connectivity (ICA100 edge 605) | GCST90005458 | 0.01 |
| 10456 | LTBR/TNFRSF14 ratio | GCST90315340 | 0.01 |
| 10457 | Ectopic pregnancy | GCST90272883 | 0.01 |
| 10458 | ICD10 O00: Ectopic pregnancy | GCST90454227 | 0.01 |
| 10459 | Loud music exposure frequency | Hearing | UKBB00000410 | 0.01 |
| 10460 | UMOD levels | GCST90471009 | 0.01 |
| 10461 | CCL15 levels | GCST90468567 | 0.01 |
| 10462 | IDP dMRI ProbtrackX L3 fma | GCST90004310 | 0.01 |
| 10463 | PARK7/TNFRSF9 ratio | GCST90315599 | 0.01 |
| 10464 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668758 | 0.01 |
| 10465 | aparc-a2009s lh volume G-oc-temp-med-Lingual | GCST90002946 | 0.01 |
| 10466 | aparc-a2009s lh thickness S-postcentral | GCST90003669 | 0.01 |
| 10467 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000175 | 0.01 |
| 10468 | T1 FreeSurfer DKT lh lateraloccipital area | GCST90384202 | 0.01 |
| 10469 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T459 | ECGU000459 | 0.01 |
| 10470 | aseg global volume-ratio BrainSegVol-to-eTIV | GCST90002612 | 0.01 |
| 10471 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85) | GCST90320904 | 0.01 |
| 10472 | IGBP1 levels | GCST90469521 | 0.01 |
| 10473 | IDP dMRI TBSS L1 Sagittal stratum R | GCST90004105 | 0.01 |
| 10474 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467 | ECGU000467 | 0.01 |
| 10475 | Other chondrocalcinosis | FING00000977 | 0.01 |
| 10476 | Diabetes / Sugar | GCST90475265 | 0.01 |
| 10477 | Chronic hepatitis C infection | GCST90018585 | 0.01 |
| 10478 | aparc-Desikan rh volume lingual | GCST90002813 | 0.01 |
| 10479 | Creatinine levels in bottom 99% of individuals by creatinine levels | GCST90566733 | 0.01 |
| 10480 | Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivity | GCST90302724 | 0.01 |
| 10481 | PODXL levels | GCST90470280 | 0.01 |
| 10482 | Frequency of travelling from home to job workplace | Employment | UKBB00000269 | 0.01 |
| 10483 | Multi-site chronic pain | Other trait | UKBB00000490 | 0.01 |
| 10484 | GTPBP2 levels | GCST90469417 | 0.01 |
| 10485 | AMY1A or AMY1B or AMY1C levels | GCST90468297 | 0.01 |
| 10486 | Brugada syndrome | GCST90295916 | 0.01 |
| 10487 | Alcohol abuse, main dg (more control exclusions) | FING00000049 | 0.01 |
| 10488 | PDLIM7 levels | GCST90470198 | 0.01 |
| 10489 | Qualifications - None of the above | Education | UKBB00000729 | 0.01 |
| 10490 | COMMD1 levels | GCST90468825 | 0.01 |
| 10491 | Number of days/week of vigorous physical activity 10+ minutes | Physical activity | UKBB00000534 | 0.01 |
| 10492 | Phospholipids to total lipids in small HDL percentage (UKB data field 23644) | GCST90269741 | 0.01 |
| 10493 | Alanine levels | GCST90497086 | 0.01 |
| 10494 | Hemoglobin concentration variance | GCST90565685 | 0.01 |
| 10495 | HLAE/IL15 ratio | GCST90315061 | 0.01 |
| 10496 | Lung function (FVC) | GCST90025998 | 0.01 |
| 10497 | Blood urea nitrogen (BUN, minimum, inv-norm transformed) | GCST90475168 | 0.01 |
| 10498 | Plays computer games | Electronic device use | UKBB00000649 | 0.01 |
| 10499 | Takes medication for high blood pressure? | GCST90475216 | 0.01 |
| 10500 | Educational attainment (confirmatory factor analysis Factor 10) | GCST90309344 | 0.01 |
| 10501 | Intrinsic epigenetic age acceleration | GCST90014290 | 0.01 |
| 10502 | Mean corpuscular haemoglobin (UKB data field 30050) | GCST90468084 | 0.01 |
| 10503 | aparc-a2009s rh area S-orbital-H-Shaped | GCST90003434 | 0.01 |
| 10504 | Phosphatidylethanolamine_40:6_[M-H]1- levels | GCST90060365 | 0.01 |
| 10505 | IDP dMRI TBSS L2 Posterior corona radiata R | GCST90004149 | 0.01 |
| 10506 | IgA nephropathy (IgA glomerulonephritis) | FING00000660 | 0.01 |
| 10507 | Volume of right basal nucleus | GCST90475012 | 0.01 |
| 10508 | PPM1F levels | GCST90470297 | 0.01 |
| 10509 | Volume of left basal nucleus | GCST90474946 | 0.01 |
| 10510 | Stroke, excluding SAH | FING00001337 | 0.01 |
| 10511 | Estimated glomerular filtration rate (creatinine, cystatin c) | GCST90428446 | 0.01 |
| 10512 | T1 FreeSurfer BA rh BA2 exvivo volume | GCST90385576 | 0.01 |
| 10513 | Other retinal disorders | FING00001094 | 0.01 |
| 10514 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90025428 | 0.01 |
| 10515 | DTI TBSS L2 Superior fronto-occipital fasciculus L | GCST90384519 | 0.01 |
| 10516 | BA-exvivo rh volume V1 | GCST90002858 | 0.01 |
| 10517 | Lactose intolerance, other/unspecified | FING00000712 | 0.01 |
| 10518 | IGLL1 levels | GCST90241473 | 0.01 |
| 10519 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480 | ECGU000480 | 0.01 |
| 10520 | Type 1 diabetes (PheCode 250.1) | GCST90475661 | 0.01 |
| 10521 | MYCT1 levels | GCST90618046 | 0.01 |
| 10522 | Principal component-derived dietary pattern 2 | GCST90133007 | 0.01 |
| 10523 | DTI autoptx L1 ifo r tract | GCST90385152 | 0.01 |
| 10524 | Grapefruit liking | GCST90094774 | 0.01 |
| 10525 | aparc-DKTatlas rh volume lingual | GCST90002904 | 0.01 |
| 10526 | HippSubfield rh volume subiculum-body | GCST90002691 | 0.01 |
| 10527 | Prescriptions - stimulant laxative|laxative | UKBB00000702 | 0.01 |
| 10528 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32) | GCST90320595 | 0.01 |
| 10529 | Juvenile rheumatoid arthirtis | FING00000706 | 0.01 |
| 10530 | LPP levels | GCST90469790 | 0.01 |
| 10531 | PSAPL1 levels | GCST90470350 | 0.01 |
| 10532 | Eye conditions (confirmatory factor analysis Factor 25) | GCST90309359 | 0.01 |
| 10533 | Fasting plasma glucose | GCST90566420 | 0.01 |
| 10534 | Pulse pressure | GCST90301702 | 0.01 |
| 10535 | Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity | GCST90101829 | 0.01 |
| 10536 | Hemoglobin | GCST90278631 | 0.01 |
| 10537 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456 | ECGU000456 | 0.01 |
| 10538 | GP1BA/SELP ratio | GCST90314958 | 0.01 |
| 10539 | Cholesteryl Esters in LDL | GCST90498363 | 0.01 |
| 10540 | T1 FreeSurfer aseg Left-Caudate | GCST90384144 | 0.01 |
| 10541 | CEACAM19 levels | GCST90468691 | 0.01 |
| 10542 | SCARF2 levels | GCST90470537 | 0.01 |
| 10543 | APOA4 levels | GCST90468333 | 0.01 |
| 10544 | FAM3B/GPA33 ratio | GCST90314778 | 0.01 |
| 10545 | BMI and adiposity (confirmatory factor analysis Factor 7) | GCST90309342 | 0.01 |
| 10546 | IDP dMRI TBSS MO Fornix | GCST90003957 | 0.01 |
| 10547 | Peritonsillar abscess | FING00001160 | 0.01 |
| 10548 | High myopia | GCST009962 | 0.01 |
| 10549 | Sensitivity / hurt feelings | Mental health | UKBB00000766 | 0.01 |
| 10550 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451 | ECGU000451 | 0.01 |
| 10551 | Asthma/COPD (KELA code 203) | FING00000121 | 0.01 |
| 10552 | Hypertension | FING00000637 | 0.01 |
| 10553 | MAP2K6 levels | GCST90469852 | 0.01 |
| 10554 | ATXN10 levels | GCST90468401 | 0.01 |
| 10555 | Nap during day | Sleep | UKBB00000492 | 0.01 |
| 10556 | Coffee type: Instant coffee (UKB data field 1508_2) | GCST90041802 | 0.01 |
| 10557 | Cerebrospinal fluid proline levels | GCST90318251 | 0.01 |
| 10558 | B2M levels | GCST90468409 | 0.01 |
| 10559 | IDP dMRI ProbtrackX L2 fma | GCST90004283 | 0.01 |
| 10560 | Angina pectoris | FING00000086 | 0.01 |
| 10561 | Beer or cider consumption (glasses per month) (UKB data field 1578, 4420) | GCST90132988 | 0.01 |
| 10562 | aparc-pial lh area supramarginal | GCST90003171 | 0.01 |
| 10563 | CELA3A/CPA1 ratio | GCST90314009 | 0.01 |
| 10564 | PNLIP levels | GCST90470275 | 0.01 |
| 10565 | Biological Mother: Cancer, Breast | GCST90475485 | 0.01 |
| 10566 | Hypotaurine levels | GCST90200379 | 0.01 |
| 10567 | NFX1 levels | GCST90470041 | 0.01 |
| 10568 | 1-arachidonoylglycerophosphoethanolamine levels | GCST90243808 | 0.01 |
| 10569 | Medication use (drugs used in diabetes) | GCST90018761 | 0.01 |
| 10570 | Vitamin D | Blood biochemistry | UKBB00000902 | 0.01 |
| 10571 | PPIE levels | GCST90242217 | 0.01 |
| 10572 | CLIP2 levels | GCST90468782 | 0.01 |
| 10573 | Umbilical hernia | Hernia | UKBB00000881 | 0.01 |
| 10574 | Impedance of arm (right) | Impedance measures | UKBB00000357 | 0.01 |
| 10575 | TEX101 levels | GCST90470832 | 0.01 |
| 10576 | Disorder of skin and subcutaneous tissue NO (PheCode 689) | GCST90476169 | 0.01 |
| 10577 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320866 | 0.01 |
| 10578 | DTI TBSS L3 Fornix cres+Stria terminalis L | GCST90384563 | 0.01 |
| 10579 | OTUD6B levels | GCST90470136 | 0.01 |
| 10580 | Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers) | FING00000752 | 0.01 |
| 10581 | Hypertension (confirmatory factor analysis Factor 12) | GCST90309346 | 0.01 |
| 10582 | Hip circumference adjusted for BMI | GCST012227 | 0.01 |
| 10583 | CX3CL1/DSG2 ratio | GCST90314323 | 0.01 |
| 10584 | IDP dMRI ProbtrackX FA ar l | GCST90003925 | 0.01 |
| 10585 | Spherical power (right) | Autorefraction | UKBB00000791 | 0.01 |
| 10586 | FABP6 levels | GCST90469178 | 0.01 |
| 10587 | Intestinal infectious diseases | FING00000689 | 0.01 |
| 10588 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | GCST90320903 | 0.01 |
| 10589 | IDP dMRI TBSS L1 Cingulum hippocampus R | GCST90004111 | 0.01 |
| 10590 | EPHB6/LAYN ratio | GCST90314681 | 0.01 |
| 10591 | VSIG2 levels | GCST90471051 | 0.01 |
| 10592 | Major dietary changes in the last 5 years - Yes, because of other reasons | Diet | UKBB00000423 | 0.01 |
| 10593 | RBKS levels | GCST90470433 | 0.01 |
| 10594 | Hypothyroidism, strict autoimmune | FING00000656 | 0.01 |
| 10595 | Polyneuropathy in diabetes (PheCode 250.6) | GCST90475686 | 0.01 |
| 10596 | T1 FreeSurfer DKT rh fusiform thickness | GCST90384322 | 0.01 |
| 10597 | Belittlement by partner or ex-partner as an adult | Traumatic events | UKBB00000091 | 0.01 |
| 10598 | T1 FreeSurfer a2009s lh S temporal sup area | GCST90384740 | 0.01 |
| 10599 | Insomnia complaints | GCST004695 | 0.01 |
| 10600 | Disorders of choroid and retina | FING00000438 | 0.01 |
| 10601 | Cataracts | GCST90475382 | 0.01 |
| 10602 | BCL2 levels | GCST90468433 | 0.01 |
| 10603 | Avocado liking | GCST90094694 | 0.01 |
| 10604 | Treatment speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000832 | 9.97e-03 |
| 10605 | Cancer (standard GWA) | GCST90267270 | 9.97e-03 |
| 10606 | Alcohol frequency weekly (standard GWA) | GCST90267266 | 9.97e-03 |
| 10607 | Type 1 diabetes with ophthalmic manifestations (PheCode 250.13) | GCST90475663 | 9.91e-03 |
| 10608 | Inguinal hernia | FING00000681 | 9.88e-03 |
| 10609 | GP1BB levels | GCST90469381 | 9.87e-03 |
| 10610 | Phospholipids in LDL | GCST90498439 | 9.84e-03 |
| 10611 | TACC3/TBC1D23 ratio | GCST90315900 | 9.81e-03 |
| 10612 | Other disorders of ear | FING00001023 | 9.76e-03 |
| 10613 | CCN5/IGFBP6 ratio | GCST90313723 | 9.75e-03 |
| 10614 | Clinical LDL cholesterol levels | GCST90497223 | 9.74e-03 |
| 10615 | Tooth agenesis EXCLUDE clefts and syndromes | FING00001368 | 9.74e-03 |
| 10616 | Left-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302660 | 9.74e-03 |
| 10617 | aparc-pial rh area inferiorparietal | GCST90003181 | 9.72e-03 |
| 10618 | Reaction time (baseline) | GCST90565838 | 9.72e-03 |
| 10619 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320688 | 9.71e-03 |
| 10620 | RELL1 levels | GCST90242625 | 9.70e-03 |
| 10621 | NSFL1C/PSMG3 ratio | GCST90315559 | 9.68e-03 |
| 10622 | Hair/balding pattern: Pattern 4 (UKB data field 2395_4) | GCST90043619 | 9.67e-03 |
| 10623 | Creatinine levels (UKB data field 30700) | GCST90468067 | 9.64e-03 |
| 10624 | wg lh intensity-contrast transversetemporal | GCST90003825 | 9.64e-03 |
| 10625 | AMBP/ASGR1 ratio | GCST90313251 | 9.63e-03 |
| 10626 | Arabitol/xylitol levels | GCST90200011 | 9.62e-03 |
| 10627 | RUNX3 levels | GCST90242706 | 9.52e-03 |
| 10628 | BA-exvivo rh thickness V2 | GCST90003537 | 9.52e-03 |
| 10629 | Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivity | GCST90302735 | 9.51e-03 |
| 10630 | EHBP1 levels | GCST90469088 | 9.50e-03 |
| 10631 | LTBR levels | GCST90469816 | 9.50e-03 |
| 10632 | ERBB2/PTPRF ratio | GCST90314688 | 9.49e-03 |
| 10633 | GLOD4/MIF ratio | GCST90314939 | 9.46e-03 |
| 10634 | mean corpuscular hemoglobin (MCH, mean, inv-norm transformed) | GCST90475444 | 9.46e-03 |
| 10635 | Trouble falling asleep when you first go to bed | GCST90476385 | 9.40e-03 |
| 10636 | TNC levels | GCST90470895 | 9.40e-03 |
| 10637 | SMAD1/ZBTB16 ratio | GCST90315853 | 9.38e-03 |
| 10638 | NECTIN2 levels | GCST90470020 | 9.33e-03 |
| 10639 | Creatinine | Blood biochemistry | UKBB00000156 | 9.27e-03 |
| 10640 | Nontoxic diffuse goitre | FING00000886 | 9.26e-03 |
| 10641 | HBB levels | GCST90025969 | 9.25e-03 |
| 10642 | MICB or MICA levels | GCST90469905 | 9.22e-03 |
| 10643 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439 | ECGU000439 | 9.19e-03 |
| 10644 | ESAM/TGFB1 ratio | GCST90314718 | 9.18e-03 |
| 10645 | ICD10 O20: Haemorrhage in early pregnancy | GCST90454235 | 9.17e-03 |
| 10646 | aseg lh volume Caudate | GCST90002621 | 9.13e-03 |
| 10647 | IDP dMRI TBSS L3 Middle cerebellar peduncle | GCST90004171 | 9.12e-03 |
| 10648 | TG levels | GCST90470851 | 9.12e-03 |
| 10649 | DTI TBSS MD Fornix | GCST90384577 | 9.10e-03 |
| 10650 | DTI TBSS L2 Anterior limb of internal capsule R | GCST90384492 | 9.10e-03 |
| 10651 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 9.05e-03 |
| 10652 | Plasma N-acetyltaurine levels in chronic kidney disease | GCST90265600 | 9.03e-03 |
| 10653 | Diacylglycerol_32:2_[M+H-H2O]1+ levels | GCST90060168 | 8.99e-03 |
| 10654 | BRAP levels | GCST90468464 | 8.95e-03 |
| 10655 | CTRC levels | GCST90468906 | 8.94e-03 |
| 10656 | mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed) | GCST90475448 | 8.94e-03 |
| 10657 | aparc-DKTatlas lh thickness postcentral | GCST90003560 | 8.93e-03 |
| 10658 | Overweight, obesity and other hyperalimentation (PheCode 278) | GCST90475759 | 8.92e-03 |
| 10659 | Age at onset of walking | GCST90651078 | 8.92e-03 |
| 10660 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 8.80e-03 |
| 10661 | aparc-Desikan rh volume parstriangularis | GCST90002820 | 8.79e-03 |
| 10662 | Sphingomyelin_41:2_[M+H]1+ levels | GCST90060383 | 8.77e-03 |
| 10663 | Roast chicken liking | GCST90094821 | 8.76e-03 |
| 10664 | Never eat sugar vs no sugar restrictions (UKB data field 6144) | GCST90132934 | 8.75e-03 |
| 10665 | Other peripheral nerve disorders | neurological | UKBB00000618 | 8.75e-03 |
| 10666 | SLITRK6 levels | GCST90470671 | 8.74e-03 |
| 10667 | aparc-a2009s rh area G+S-occipital-inf | GCST90003372 | 8.73e-03 |
| 10668 | Hematocrit | GCST90002383 | 8.73e-03 |
| 10669 | Allergic contact dermatitis | FING00000068 | 8.72e-03 |
| 10670 | Right subiculum volume (body) | GCST90267980 | 8.72e-03 |
| 10671 | Coronary artery plaque burden | GCST90503075 | 8.69e-03 |
| 10672 | Enterocolitis due to Clostridium difficile | FING00000507 | 8.68e-03 |
| 10673 | CX3CL1 levels | GCST90241204 | 8.66e-03 |
| 10674 | Omega-6 fatty acid levels | GCST90502100 | 8.63e-03 |
| 10675 | aparc-Desikan rh area precuneus | GCST90003131 | 8.62e-03 |
| 10676 | IDP T1 FAST ROIs L cuneal cortex | GCST90002513 | 8.61e-03 |
| 10677 | QC T1-to-standard nonlinear alignment discrepancy | GCST90006346 | 8.60e-03 |
| 10678 | EPHB4 levels | GCST90469132 | 8.57e-03 |
| 10679 | AMY2B levels | GCST90468299 | 8.55e-03 |
| 10680 | CD160/NCR1 ratio | GCST90313732 | 8.53e-03 |
| 10681 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 10) | GCST90320829 | 8.52e-03 |
| 10682 | Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers) | FING00000754 | 8.46e-03 |
| 10683 | DTI TBSS FA External capsule L | GCST90384413 | 8.39e-03 |
| 10684 | Beta-hydroxyisovaleroylcarnitine levels | GCST90199802 | 8.39e-03 |
| 10685 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126) | GCST90320689 | 8.37e-03 |
| 10686 | RNF41 levels | GCST90470485 | 8.36e-03 |
| 10687 | Total Lipids in LDL | GCST90498405 | 8.35e-03 |
| 10688 | Ascending aorta distensibility | GCST90267385 | 8.30e-03 |
| 10689 | BA-exvivo rh volume BA4p | GCST90002854 | 8.27e-03 |
| 10690 | Linoleic acid levels | GCST90502009 | 8.23e-03 |
| 10691 | Hemoglobin | GCST90002384 | 8.22e-03 |
| 10692 | IDP dMRI TBSS MD Posterior limb of internal capsule L | GCST90004046 | 8.18e-03 |
| 10693 | Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132933 | 8.16e-03 |
| 10694 | DTI autoptx L3 ptr r tract | GCST90385213 | 8.12e-03 |
| 10695 | Back pain | symptoms | UKBB00000084 | 8.10e-03 |
| 10696 | IDP T1 FAST ROIs L subcallosal cortex | GCST90002503 | 8.07e-03 |
| 10697 | Postmenopausal breast cancer | GCST90428116 | 8.06e-03 |
| 10698 | PRSS2 levels | GCST90470343 | 8.06e-03 |
| 10699 | X-18922 levels | GCST90200578 | 8.05e-03 |
| 10700 | JAM2/TGFBR2 ratio | GCST90315238 | 8.01e-03 |
| 10701 | aparc-a2009s rh volume Pole-occipital | GCST90003040 | 7.98e-03 |
| 10702 | Principal component-derived dietary pattern 40 | GCST90133045 | 7.95e-03 |
| 10703 | Haemoglobin concentration | Blood count | UKBB00000293 | 7.95e-03 |
| 10704 | ThalamNuclei rh volume MGN | GCST90002737 | 7.93e-03 |
| 10705 | Right-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302845 | 7.92e-03 |
| 10706 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025743 | 7.92e-03 |
| 10707 | CCN3 levels | GCST90242492 | 7.92e-03 |
| 10708 | Mean corpuscular volume | Blood count | UKBB00000449 | 7.92e-03 |
| 10709 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | GCST90475285 | 7.91e-03 |
| 10710 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23 | ECGA000023 | 7.86e-03 |
| 10711 | Dried fruit consumption | GCST90132980 | 7.85e-03 |
| 10712 | HippSubfield lh volume Whole-hippocampal-head | GCST90002688 | 7.83e-03 |
| 10713 | Acute pancreatitis | FING00000027 | 7.82e-03 |
| 10714 | Total cerebellar volume (excluding Crus I vermis) | GCST90020190 | 7.81e-03 |
| 10715 | Alanine levels (UKB data field 23460) | GCST90269557 | 7.78e-03 |
| 10716 | Frequency of tiredness / lethargy in last 2 weeks | Mental health | UKBB00000268 | 7.77e-03 |
| 10717 | potassium (minimum, inv-norm transformed) | GCST90476310 | 7.75e-03 |
| 10718 | Pancreas volume | GCST90016669 | 7.72e-03 |
| 10719 | RPN1 levels | GCST90240964 | 7.67e-03 |
| 10720 | Bladder stone | GCST90468116 | 7.66e-03 |
| 10721 | systolic blood pressure (SBP, maximum, inv-normal transformed) | GCST90476400 | 7.65e-03 |
| 10722 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T231 | ECGA000231 | 7.63e-03 |
| 10723 | Height | GCST90018739 | 7.62e-03 |
| 10724 | CD93 levels | GCST90468656 | 7.60e-03 |
| 10725 | Weight change compared with 1 year ago | General health | UKBB00000911 | 7.57e-03 |
| 10726 | Viral hepatitis C (PheCode 70.3) | GCST90475553 | 7.57e-03 |
| 10727 | Bipolar disorder | GCST003724 | 7.49e-03 |
| 10728 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7) | GCST90320570 | 7.47e-03 |
| 10729 | Right ventricular end systolic volume | GCST90134589 | 7.41e-03 |
| 10730 | DTI TBSS L1 Cingulum cingulate gyrus L | GCST90384463 | 7.38e-03 |
| 10731 | Umbilical hernia | digestive | UKBB00000880 | 7.35e-03 |
| 10732 | DNAJC9 levels | GCST90469018 | 7.34e-03 |
| 10733 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36) | GCST90320855 | 7.33e-03 |
| 10734 | Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | Diet | UKBB00000501 | 7.32e-03 |
| 10735 | Trauma exposure | GCST009982 | 7.29e-03 |
| 10736 | HippSubfield rh volume molecular-layer-HP-head | GCST90002699 | 7.28e-03 |
| 10737 | Right-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302835 | 7.28e-03 |
| 10738 | aparc-a2009s rh volume G-pariet-inf-Supramar | GCST90003024 | 7.27e-03 |
| 10739 | GRHPR levels | GCST90469400 | 7.26e-03 |
| 10740 | aseg rh volume Cerebellum-Cortex | GCST90002636 | 7.21e-03 |
| 10741 | NPPB levels | GCST90470074 | 7.19e-03 |
| 10742 | Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivity | GCST90302733 | 7.19e-03 |
| 10743 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 7.13e-03 |
| 10744 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432179 | 7.12e-03 |
| 10745 | Cirrhosis | GCST90018606 | 7.09e-03 |
| 10746 | Dermatitis and eczema | FING00000402 | 7.07e-03 |
| 10747 | Scar conditions and fibrosis of skin (PheCode 701.2) | GCST90476198 | 7.06e-03 |
| 10748 | Non-cancer illness code, self-reported - type 2 diabetes | Medical conditions | UKBB00000522 | 7.05e-03 |
| 10749 | Pulse pressure | GCST90301703 | 7.04e-03 |
| 10750 | Ceramide (d16:1/22:0) levels | GCST90024026 | 7.03e-03 |
| 10751 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454 | ECGU000454 | 7.01e-03 |
| 10752 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320607 | 7.00e-03 |
| 10753 | Left-hemisphere control network to caudate white-matter structural connectivity | GCST90302753 | 7.00e-03 |
| 10754 | LGALS3 levels | GCST90179303 | 7.00e-03 |
| 10755 | aparc-Desikan rh thickness GlobalMeanThickness | GCST90003479 | 6.99e-03 |
| 10756 | X-25371 levels | GCST90200656 | 6.98e-03 |
| 10757 | IL13RA1 levels | GCST90469552 | 6.95e-03 |
| 10758 | GRAP2/MAP4K5 ratio | GCST90314982 | 6.90e-03 |
| 10759 | Left-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302699 | 6.90e-03 |
| 10760 | AMOT levels | GCST90468295 | 6.86e-03 |
| 10761 | AmygNuclei lh volume Lateral-nucleus | GCST90002648 | 6.85e-03 |
| 10762 | Secondary hypertension | FING00001285 | 6.84e-03 |
| 10763 | IDP dMRI TBSS FA Anterior limb of internal capsule L | GCST90003894 | 6.83e-03 |
| 10764 | PPL levels | GCST90470294 | 6.81e-03 |
| 10765 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90025432 | 6.80e-03 |
| 10766 | Endometriosis of pelvic peritoneum | FING00000502 | 6.80e-03 |
| 10767 | Principal component-derived dietary pattern 36 | GCST90133041 | 6.80e-03 |
| 10768 | Anaemias | FING00000082 | 6.78e-03 |
| 10769 | Left-hemisphere control network to amygdala white-matter structural connectivity | GCST90302757 | 6.77e-03 |
| 10770 | Colon polyp | GCST90018607 | 6.77e-03 |
| 10771 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320905 | 6.76e-03 |
| 10772 | FAM3B/GUCA2A ratio | GCST90314779 | 6.76e-03 |
| 10773 | Total lipids in small LDL | GCST90499656 | 6.72e-03 |
| 10774 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle R | GCST90004337 | 6.72e-03 |
| 10775 | FOLR1 levels | GCST90469259 | 6.69e-03 |
| 10776 | Phosphatidylcholine (14:0_22:6) levels | GCST90024234 | 6.69e-03 |
| 10777 | Osteoarthritis, localized (PheCode 740.1) | GCST90476254 | 6.69e-03 |
| 10778 | Primary Raynaud’s phenomenon | GCST90271714 | 6.68e-03 |
| 10779 | Biliary atresia | GCST90296484 | 6.67e-03 |
| 10780 | N-palmitoyl-heptadecasphingosine (d17:1/16:0) levels | GCST90200115 | 6.66e-03 |
| 10781 | BA-exvivo rh volume BA3a | GCST90002851 | 6.65e-03 |
| 10782 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T496 | ECGA000496 | 6.64e-03 |
| 10783 | CEACAM16 levels | GCST90468689 | 6.64e-03 |
| 10784 | Bread consumption (slices per week) (UKB data field 1438) | GCST90132981 | 6.62e-03 |
| 10785 | Smoking status (weighted GWA) | GCST90267303 | 6.58e-03 |
| 10786 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90024504 | 6.56e-03 |
| 10787 | TNFRSF4/TNFRSF9 ratio | GCST90315939 | 6.56e-03 |
| 10788 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475460 | 6.55e-03 |
| 10789 | ThalamNuclei rh volume MDl | GCST90002748 | 6.55e-03 |
| 10790 | PIK3AP1 levels | GCST90470233 | 6.55e-03 |
| 10791 | BA-exvivo lh volume BA2 | GCST90002836 | 6.52e-03 |
| 10792 | Hemoglobin A1c levels | GCST90278632 | 6.42e-03 |
| 10793 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450 | ECGU000450 | 6.41e-03 |
| 10794 | IL15RA levels | GCST90469555 | 6.40e-03 |
| 10795 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000179 | 6.39e-03 |
| 10796 | Benign neoplasm of major salivary glands | FING00000157 | 6.39e-03 |
| 10797 | aseg lh volume Inf-Lat-Vent | GCST90002617 | 6.38e-03 |
| 10798 | Alcohol usually taken with meals | Alcohol | UKBB00000025 | 6.35e-03 |
| 10799 | Left-hemisphere salience/ventral attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302711 | 6.34e-03 |
| 10800 | aparc-pial rh area lateraloccipital | GCST90003184 | 6.33e-03 |
| 10801 | Hernia | FING00000616 | 6.30e-03 |
| 10802 | PAPPA levels | GCST90012036 | 6.28e-03 |
| 10803 | Fasting glucose | GCST90002231 | 6.26e-03 |
| 10804 | Principal component-derived dietary pattern 30 | GCST90133035 | 6.25e-03 |
| 10805 | creatinine (maximum, inv-norm transformed) | GCST90475226 | 6.25e-03 |
| 10806 | Volume of right anterior amygdaloid area | GCST90475000 | 6.25e-03 |
| 10807 | ST6GALNAC2 levels | GCST90240251 | 6.23e-03 |
| 10808 | Alcoholic liver disease | FING00000057 | 6.22e-03 |
| 10809 | IDP dMRI TBSS L2 Inferior cerebellar peduncle R | GCST90004133 | 6.21e-03 |
| 10810 | AKT2 levels | GCST90468277 | 6.21e-03 |
| 10811 | EBAG9/MITD1 ratio | GCST90314566 | 6.21e-03 |
| 10812 | Urine N-acetylglutamate levels in chronic kidney disease | GCST90265569 | 6.20e-03 |
| 10813 | Migraine without aura and triptan purchases | FING00000822 | 6.16e-03 |
| 10814 | LTBR levels | GCST90243176 | 6.15e-03 |
| 10815 | Other embolism and thrombosis | FING00001043 | 6.14e-03 |
| 10816 | Sjögren's syndrome | GCST90018700 | 6.13e-03 |
| 10817 | Pulse pressure | GCST90472785 | 6.12e-03 |
| 10818 | Mood swings | Mental health | UKBB00000482 | 6.10e-03 |
| 10819 | Red blood cell count | GCST90002403 | 6.07e-03 |
| 10820 | aparc-Desikan lh thickness postcentral | GCST90003466 | 6.06e-03 |
| 10821 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 6.05e-03 |
| 10822 | Mouth/teeth dental problems - None of the above | Mouth | UKBB00000489 | 6.05e-03 |
| 10823 | Cholesteryl Esters in VLDL | GCST90500205 | 6.05e-03 |
| 10824 | MME levels | GCST90469914 | 6.05e-03 |
| 10825 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 6.04e-03 |
| 10826 | Participation in an health questionnaire (not invited vs invited) | GCST90012794 | 6.03e-03 |
| 10827 | BSG/PCDH1 ratio | GCST90313535 | 6.03e-03 |
| 10828 | HippSubfield lh volume GC-ML-DG-head | GCST90002679 | 6.02e-03 |
| 10829 | Phlebitis and thrombophlebitis (PheCode 451) | GCST90476003 | 6.00e-03 |
| 10830 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475456 | 5.99e-03 |
| 10831 | Cylindrical power (right) | Autorefraction | UKBB00000162 | 5.98e-03 |
| 10832 | Calculus of lower urinary tract | FING00000237 | 5.96e-03 |
| 10833 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457 | ECGU000457 | 5.95e-03 |
| 10834 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R | GCST90004213 | 5.93e-03 |
| 10835 | Type 2 diabetes | GCST90018706 | 5.92e-03 |
| 10836 | EHMT2 levels | GCST90241442 | 5.92e-03 |
| 10837 | IDP dMRI TBSS ICVF Medial lemniscus L | GCST90004336 | 5.91e-03 |
| 10838 | Treatment/medication code - perindopril | Medications | UKBB00000854 | 5.90e-03 |
| 10839 | Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448) | GCST90132968 | 5.89e-03 |
| 10840 | Acute bronchitis | FING00000021 | 5.88e-03 |
| 10841 | Dried fruit liking | GCST90094756 | 5.86e-03 |
| 10842 | AK1 levels | GCST90468269 | 5.86e-03 |
| 10843 | Leiomyoma of uterus | FING00000719 | 5.85e-03 |
| 10844 | Dried fruit intake | Diet | UKBB00000193 | 5.85e-03 |
| 10845 | Diastolic blood pressure | GCST90025981 | 5.84e-03 |
| 10846 | Coxarthrosis, primary, with hip surgery | FING00000364 | 5.82e-03 |
| 10847 | IDP dMRI TBSS L1 Uncinate fasciculus L | GCST90004120 | 5.82e-03 |
| 10848 | CLMP levels | GCST90468783 | 5.79e-03 |
| 10849 | Unspecified monoarthritis | musculoskeletal | UKBB00000882 | 5.77e-03 |
| 10850 | Hip circumference (UKB data field 49) | GCST90468170 | 5.76e-03 |
| 10851 | ESAM/FUT8 ratio | GCST90314711 | 5.75e-03 |
| 10852 | Impedance of arm (left) | Impedance measures | UKBB00000356 | 5.74e-03 |
| 10853 | Open wounds of extremities (PheCode 871) | GCST90476285 | 5.73e-03 |
| 10854 | GSTA4 levels | GCST90241283 | 5.72e-03 |
| 10855 | Haematocrit percentage | Blood count | UKBB00000292 | 5.71e-03 |
| 10856 | Cataracts | GCST90018594 | 5.71e-03 |
| 10857 | SSNA1 levels | GCST90470750 | 5.70e-03 |
| 10858 | T1 FreeSurfer aseg Right-Caudate | GCST90384162 | 5.69e-03 |
| 10859 | T1 FreeSurfer DK rh lateraloccipital volume | GCST90385767 | 5.69e-03 |
| 10860 | Disorders of vestibular function (Vertigo) | FING00000464 | 5.62e-03 |
| 10861 | Cerebral amyloid angiopathy | FING00000262 | 5.62e-03 |
| 10862 | DARS1 levels | GCST90468947 | 5.60e-03 |
| 10863 | T1 FreeSurfer DK lh precentral thickness | GCST90385645 | 5.60e-03 |
| 10864 | Bread intake | Diet | UKBB00000105 | 5.58e-03 |
| 10865 | Syncope and collapse | symptoms | UKBB00000801 | 5.57e-03 |
| 10866 | Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers) | FING00000771 | 5.56e-03 |
| 10867 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000174 | 5.56e-03 |
| 10868 | Breast cancer | GCST007236 | 5.55e-03 |
| 10869 | aparc-Desikan rh area inferiorparietal | GCST90003114 | 5.54e-03 |
| 10870 | Brugada syndrome | GCST90086158 | 5.54e-03 |
| 10871 | Estimated glomerular filtration rate, serum creatinine | Other measurement | UKBB00000212 | 5.54e-03 |
| 10872 | DTI autoptx L1 ilf l tract | GCST90385153 | 5.53e-03 |
| 10873 | DTI autoptx L2 atr l tract | GCST90385168 | 5.49e-03 |
| 10874 | aparc-DKTatlas rh area inferiorparietal | GCST90003271 | 5.49e-03 |
| 10875 | PDLIM5 levels | GCST90470197 | 5.48e-03 |
| 10876 | Diastolic blood pressure, automated reading | Blood pressure | UKBB00000173 | 5.44e-03 |
| 10877 | Medication use (agents acting on the renin-angiotensin system) | GCST90018768 | 5.43e-03 |
| 10878 | Attention deficit hyperactivity disorder (ADuLT model adjusted for sex) | GCST90275136 | 5.43e-03 |
| 10879 | IDP dMRI TBSS MD Body of corpus callosum | GCST90004030 | 5.42e-03 |
| 10880 | ADM/CLMP ratio | GCST90313197 | 5.41e-03 |
| 10881 | Hot drink temperature | Diet | UKBB00000329 | 5.40e-03 |
| 10882 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T234 | ECGA000234 | 5.38e-03 |
| 10883 | Immature fraction of reticulocytes | GCST004628 | 5.37e-03 |
| 10884 | Preterm labour and delivery | FING00001209 | 5.37e-03 |
| 10885 | rfMRI connectivity (ICA100 edge 614) | GCST90005467 | 5.34e-03 |
| 10886 | aparc-Desikan rh volume lateraloccipital | GCST90002811 | 5.33e-03 |
| 10887 | CEACAM20 levels | GCST90468693 | 5.31e-03 |
| 10888 | Benign neoplasm: Rectum | FING00000196 | 5.31e-03 |
| 10889 | Forced expiratory volume in 1-second (FEV1), predicted percentage | Spirometry | UKBB00000253 | 5.27e-03 |
| 10890 | IDP dMRI TBSS MD External capsule L | GCST90004060 | 5.27e-03 |
| 10891 | Alanine aminotransferase levels | GCST90278617 | 5.27e-03 |
| 10892 | Eosinophil count variance | GCST90565689 | 5.26e-03 |
| 10893 | aparc-a2009s lh volume S-calcarine | GCST90002968 | 5.25e-03 |
| 10894 | aparc-a2009s rh area G-oc-temp-med-Lingual | GCST90003392 | 5.24e-03 |
| 10895 | aparc-Desikan lh area lingual | GCST90003085 | 5.24e-03 |
| 10896 | Other obstetric trauma | FING00001082 | 5.21e-03 |
| 10897 | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302806 | 5.19e-03 |
| 10898 | Sodium (mean, inv-norm transformed) | GCST90476395 | 5.18e-03 |
| 10899 | Retinal thickness (functional principal component 3) | GCST90455723 | 5.17e-03 |
| 10900 | Spondylosis without myelopathy (PheCode 721.1) | GCST90476236 | 5.17e-03 |
| 10901 | Operative procedures - Unspecified diagnostic endoscopic examination of bladder | Summary Operations | UKBB00000590 | 5.14e-03 |
| 10902 | Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levels | GCST90566737 | 5.13e-03 |
| 10903 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000177 | 5.13e-03 |
| 10904 | GPIHBP1 levels | GCST90469390 | 5.13e-03 |
| 10905 | ICD10 N87: Dysplasia of cervix uteri | GCST90454218 | 5.12e-03 |
| 10906 | Fasting blood glucose | GCST000568 | 5.12e-03 |
| 10907 | FEV1/FVC ratio | Other measurement | UKBB00000245 | 5.12e-03 |
| 10908 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55 | ECGA000055 | 5.10e-03 |
| 10909 | UBAC1 levels | GCST90470999 | 5.10e-03 |
| 10910 | IDP dMRI TBSS L2 Corticospinal tract R | GCST90004129 | 5.09e-03 |
| 10911 | CLIC5 levels | GCST90421740 | 5.08e-03 |
| 10912 | Phlebitis and thrombophlebitis (not including DVT) | FING00001165 | 5.04e-03 |
| 10913 | Disorders of breast | FING00000437 | 5.02e-03 |
| 10914 | T1 FreeSurfer DKT rh lateraloccipital area | GCST90384295 | 5.01e-03 |
| 10915 | DTI TBSS L2 Cingulum hippocampus L | GCST90384513 | 5.00e-03 |
| 10916 | Osteoarthritis | GCST90134279 | 4.99e-03 |
| 10917 | Ever Smoker | FING00000522 | 4.98e-03 |
| 10918 | Psoriasis (vulgaris), strict definition | FING00001223 | 4.98e-03 |
| 10919 | EPO/TFRC ratio | GCST90314684 | 4.95e-03 |
| 10920 | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302700 | 4.94e-03 |
| 10921 | Edema (PheCode 782.3) | GCST90476272 | 4.94e-03 |
| 10922 | HippSubfield lh volume Whole-hippocampal-body | GCST90002687 | 4.92e-03 |
| 10923 | Diastolic blood pressure (UKB data field 4079) | GCST90468163 | 4.91e-03 |
| 10924 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90024193 | 4.91e-03 |
| 10925 | Obstructed labour due to maternal pelvic abnormality | FING00000899 | 4.88e-03 |
| 10926 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320943 | 4.88e-03 |
| 10927 | Bicarbonate (mean, inv-norm transformed) | GCST90475148 | 4.87e-03 |
| 10928 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441 | ECGU000441 | 4.87e-03 |
| 10929 | IDP dMRI TBSS L2 Superior cerebellar peduncle L | GCST90004136 | 4.86e-03 |
| 10930 | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | GCST90302765 | 4.85e-03 |
| 10931 | Chronic renal failure [CKD] (PheCode 585.3) | GCST90476123 | 4.85e-03 |
| 10932 | T1 FreeSurfer DKT rh lateraloccipital volume | GCST90384357 | 4.83e-03 |
| 10933 | T1 FreeSurfer aseg 3rd-Ventricle | GCST90384147 | 4.83e-03 |
| 10934 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458 | ECGU000458 | 4.81e-03 |
| 10935 | aparc-a2009s rh area G-pariet-inf-Angular | GCST90003395 | 4.80e-03 |
| 10936 | Age first had sexual intercourse | Sexual factors | UKBB00000014 | 4.80e-03 |
| 10937 | Panic attacks | Mental distress | UKBB00000634 | 4.79e-03 |
| 10938 | Calcium levels | GCST90018731 | 4.78e-03 |
| 10939 | Impedance of arm left (UKB data field 23110) | GCST90468171 | 4.76e-03 |
| 10940 | Chronic pain (confirmatory factor analysis Factor 18) | GCST90309352 | 4.75e-03 |
| 10941 | aparc-a2009s lh volume S-postcentral | GCST90002991 | 4.74e-03 |
| 10942 | Emotional neglect | GCST90551846 | 4.74e-03 |
| 10943 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499564 | 4.71e-03 |
| 10944 | Microscopic colitis | GCST90204144 | 4.66e-03 |
| 10945 | Right-hemisphere control network to thalamus white-matter structural connectivity | GCST90302836 | 4.66e-03 |
| 10946 | Phosphatidylcholine (34:5) levels | GCST90024286 | 4.65e-03 |
| 10947 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T212 | ECGU000212 | 4.64e-03 |
| 10948 | Mean reticulocyte volume | Blood count | UKBB00000451 | 4.60e-03 |
| 10949 | Frequency of friend/family visits | Social support | UKBB00000262 | 4.58e-03 |
| 10950 | IDP dMRI TBSS MO Posterior limb of internal capsule R | GCST90003970 | 4.57e-03 |
| 10951 | Volume of left whole amygdala | GCST90474988 | 4.53e-03 |
| 10952 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 4.53e-03 |
| 10953 | Breast conditions, congenital or relating to hormones (PheCode 612) | GCST90476162 | 4.52e-03 |
| 10954 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 4.48e-03 |
| 10955 | Hemoglobin | GCST90018737 | 4.47e-03 |
| 10956 | Pulse pressure | GCST90310296 | 4.47e-03 |
| 10957 | Lysophosphatidylcholine (24:0) [sn1] levels | GCST90025425 | 4.47e-03 |
| 10958 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489 | ECGA000489 | 4.46e-03 |
| 10959 | CUZD1 levels | GCST90468919 | 4.42e-03 |
| 10960 | AFP levels | GCST90468250 | 4.42e-03 |
| 10961 | aparc-a2009s rh volume S-collat-transv-ant | GCST90003048 | 4.42e-03 |
| 10962 | Immature fraction of reticulocytes | GCST90025971 | 4.42e-03 |
| 10963 | Mean corpuscular volume | GCST90002392 | 4.37e-03 |
| 10964 | aparc-DKTatlas lh area lingual | GCST90003245 | 4.35e-03 |
| 10965 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T47 | ECGU000047 | 4.35e-03 |
| 10966 | CD59/PI3 ratio | GCST90313858 | 4.34e-03 |
| 10967 | 5,6-dihydrouridine levels | GCST90199767 | 4.31e-03 |
| 10968 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 4.30e-03 |
| 10969 | aparc-DKTatlas rh thickness pericalcarine | GCST90003590 | 4.30e-03 |
| 10970 | TMED8 levels | GCST90470885 | 4.29e-03 |
| 10971 | Chronic obstructive pulmonary disease liability (machine learning-based score) | GCST90244098 | 4.29e-03 |
| 10972 | Endometriosis diagnosis and infertility diagnosis occurring together | FING00000499 | 4.26e-03 |
| 10973 | ICD10 C50.9: Malignant neoplasm of breast of unspecified site | GCST90043889 | 4.25e-03 |
| 10974 | Pelvic width | GCST90448911 | 4.25e-03 |
| 10975 | aparc-DKTatlas lh volume rostralmiddlefrontal | GCST90002887 | 4.22e-03 |
| 10976 | ALPP/MSLN ratio | GCST90313250 | 4.22e-03 |
| 10977 | Pelvic organ prolapse | GCST90102470 | 4.20e-03 |
| 10978 | IDP dMRI ProbtrackX ISOVF cgc r | GCST90004530 | 4.16e-03 |
| 10979 | IL1RL1 levels | GCST90241581 | 4.14e-03 |
| 10980 | Attention deficit hyperactivity disorder (adjusted for age, sex) | GCST90275147 | 4.11e-03 |
| 10981 | Retinal detachment with retinal break | FING00001259 | 4.11e-03 |
| 10982 | TNFRSF19 levels | GCST90470909 | 4.10e-03 |
| 10983 | Abnormal heart sounds (PheCode 396) | GCST90475916 | 4.09e-03 |
| 10984 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320845 | 4.08e-03 |
| 10985 | aparc-DKTatlas lh area fusiform | GCST90003239 | 4.07e-03 |
| 10986 | Left-hemisphere control network to thalamus white-matter structural connectivity | GCST90302752 | 4.05e-03 |
| 10987 | IDP dMRI ProbtrackX L1 ilf r | GCST90004261 | 4.05e-03 |
| 10988 | Left ventricular outflow tract obstruction (LVOTO), broad definition | FING00000717 | 4.03e-03 |
| 10989 | GRAP2/PTPN6 ratio | GCST90314986 | 4.03e-03 |
| 10990 | Asthma | GCST006862 | 4.03e-03 |
| 10991 | Acid reflux/GERD | GCST90475320 | 4.02e-03 |
| 10992 | T1 FreeSurfer DK lh lingual thickness | GCST90385634 | 4.00e-03 |
| 10993 | Urate | Blood biochemistry | UKBB00000884 | 3.98e-03 |
| 10994 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T492 | ECGA000492 | 3.98e-03 |
| 10995 | FADD/PTPN6 ratio | GCST90314775 | 3.97e-03 |
| 10996 | Red cell distribution width variance | GCST90565705 | 3.96e-03 |
| 10997 | Citrulline levels | GCST90243458 | 3.95e-03 |
| 10998 | Biological Mother: Coronary Artery / Coronary Heart Disease | GCST90475488 | 3.94e-03 |
| 10999 | Corneal hysteresis (left) | Intraocular pressure | UKBB00000148 | 3.93e-03 |
| 11000 | ThalamNuclei rh volume CeM | GCST90002751 | 3.92e-03 |